Volume 3, Issue 1: European Association for the Study of the Liver (EASL) (/HCV Update)
e-ViralHepatitis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 3, Issue 1)
Nurses and health care professionals involved in the care of patients with Hepatitis.
After participating in this activity, the participant will demonstrate the ability to:
- Discuss recent advances for the treatment of HCV genotype 1 infection using peginterferon/ribavirin plus direct acting antivirals (DAAs).
- Describe recent advances for the treatment of HCV genotype 2 and 3 infection using peginterferon/ribavirin plus direct-acting antivirals (DAAs) and interferon, free oral regimen.
- Evaluate emerging interferon-free regimens for the treatment of HCV genotype 1 infection.
Mark S. Sulkowski, MD
Professor of Medicine
Medical Director, Viral Hepatitis Center
Divisions of Infectious Disease and Gastroenterology/Hepatology
The Johns Hopkins University School of Medicine
- 1.00 ANCC